Cerebral Cavernous Malformation Proteins in Barrier Maintenance and Regulation

Int J Mol Sci. 2020 Jan 20;21(2):675. doi: 10.3390/ijms21020675.

Abstract

Cerebral cavernous malformation (CCM) is a disease characterized by mulberry shaped clusters of dilated microvessels, primarily in the central nervous system. Such lesions can cause seizures, headaches, and stroke from brain bleeding. Loss-of-function germline and somatic mutations of a group of genes, called CCM genes, have been attributed to disease pathogenesis. In this review, we discuss the impact of CCM gene encoded proteins on cellular signaling, barrier function of endothelium and epithelium, and their contribution to CCM and potentially other diseases.

Keywords: MEKK3; ROCK; Rho; cerebral cavernous malformation; endothelial barrier; epithelial barrier.

Publication types

  • Review

MeSH terms

  • Endothelium / physiology
  • Epithelium / physiology
  • Hemangioma, Cavernous, Central Nervous System / diagnostic imaging
  • Hemangioma, Cavernous, Central Nervous System / genetics*
  • Hemangioma, Cavernous, Central Nervous System / pathology
  • Homeostasis
  • Humans
  • Intestines / physiology
  • MAP Kinase Kinase Kinase 3 / genetics
  • MAP Kinase Kinase Kinase 3 / metabolism
  • Signal Transduction*
  • Tight Junctions / physiology
  • rhoA GTP-Binding Protein / genetics
  • rhoA GTP-Binding Protein / metabolism

Substances

  • RHOA protein, human
  • MAP Kinase Kinase Kinase 3
  • MAP3K3 protein, human
  • rhoA GTP-Binding Protein